Allscripts (MDRX) Tops Q1 EPS by 4c; Provides FY21 Revenues Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Allscripts Announces First Quarter 2021 Results
April 29, 2021 4:01 PM EDTFirst quarter GAAP EPS of $0.06; non-GAAP diluted EPS of $0.19 First quarter bookings of $194 million up 6% from the first quarter of 2020 Generated $56 million of cash flow from continuing operations and $35 million of free cash flow in the first quarter
CHICAGO--(BUSINESS WIRE)-- Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) (Allscripts) announced its financial results for the three months ended March 31, 2021.
Bookings(1) were $194 million in the first quarter of 2021. This result compares with $183 million in the first quarter of 2020. Contract revenue backlog... More
